https://www.selleckchem.com/pr....oducts/ag-120-Ivosid
Through their lifetimes, a total of 98 HCM-related morbid events occurred in 72 patients. Survival analysis revealed that patients with sarcomere gene mutations experienced those morbid events significantly more frequently, and this tendency was more prominent for lethal arrhythmic events. In our HCM cohort, patients with sarcomere gene mutations had poorer lifelong outcome. Genetic information is considered important for better management of HCM. In our HCM cohort, patients with sarcomere gene mutations had poorer lifelong ou
Curtir
Comentario
Compartilhar
